ظاهرة رينود الأولية: ماذا تفعل عندما يفشل العلاج الموسّع للأوعية الدموية عن طريق الفم في السيطرة على النوبات

References

DOI: 10.1177/1759720X17740074

• Glyceryl trinitrate (GTN) patches can be prescribed for their systemic vasodilatory effects, but are often poorly tolerated.
• A multicentre, placebo-controlled trial demonstrated benefit from a novel formulation of GTN, MQX-503, in terms of improvement in Raynaud's Condition Score.
• MQX-503 gel was applied to the fingers immediately before or within 5 min of onset of a Raynaud's attack over a 4-week period.